Lymphoma, Large B-Cell, Diffuse · Фаза 2 · NCT06890884
Zilovertamab vedotin, Rituximab, Cyclophosphamide, Doxorubicin
Merck Sharp & Dohme LLC · Open the brief
Acute Myeloid Leukemia and Myelodysplastic Syndromes After Allogeneic Transplant · Phase 1/2 · NCT06129734
Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant
Benjamin Tomlinson · Open the brief
Acute Myeloid Leukemia (AML) · Фаза 2 · NCT07060001 · Papers
5hmC Biomarker, Venetoclax, Decitabine 20 mg/m²/day for 5 days, Azacitidine (AZA)
The Methodist Hospital Research Institute · Open the brief
Recurrent Diffuse Large B-Cell Lymphoma · Фаза 2 · NCT05672251
Biopsy, Biospecimen Collection, Computed Tomography, Loncastuximab Tesirine
City of Hope Medical Center · Open the brief
Acute Myeloid Leukemia With Complex Karyotype · Фаза 2 · NCT07582172
Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography, Echocardiography Test
City of Hope Medical Center · Open the brief
Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 · Фаза 2 · NCT00801489
Cytarabine, Decitabine, Filgrastim-sndz, Fludarabine Phosphate
M.D. Anderson Cancer Center · Open the brief
Ann Arbor Stage III Grade 1 Follicular Lymphoma · Фаза 2 · NCT04404088
Acalabrutinib, Lenalidomide, Rituximab
M.D. Anderson Cancer Center · Open the brief
Refractory Acute Myeloid Leukemia · Phase 1 · NCT06017258 · Papers
CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center · Open the brief
Recurrent Chronic Lymphocytic Leukemia · Фаза 2 · NCT07061951
Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography, Echocardiography Test
National Cancer Institute (NCI) · Open the brief
NPM1-Mutated AML in Remission After Allogeneic Transplant · Phase 1 · NCT06440135
Ziftomenib Maintenance Post Allo-HCT
Massachusetts General Hospital · Open the brief
Lymphoma · Фаза 2 · NCT06563505
Mosunetuzumab, Zanubrutinib
M.D. Anderson Cancer Center · Open the brief
Myeloid Malignancies · Фаза 2 · NCT06668584
Olutasidenib
M.D. Anderson Cancer Center · Open the brief
IDH1 Mutation · Фаза 2 · NCT06707493
Ivosidenib, Placebo
Massachusetts General Hospital · Open the brief
Relapsed/Refractory Myeloma · Phase 1/2 · NCT06066359
Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R Myeloma
M.D. Anderson Cancer Center · Open the brief
Acute Myeloid Leukemia · Фаза 2 · NCT03586609 · Papers
Azacitidine, Cladribine, Cytarabine, Venetoclax
M.D. Anderson Cancer Center · Open the brief
Hodgkin's Lymphoma · Phase 1 · NCT02917083 · Papers
CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
Baylor College of Medicine · Open the brief
Large B-cell Lymphoma · Фаза 2 · NCT06500273
cemacabtagene ansegedleucel, Fludarabine, Cyclophosphamide, Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™
Allogene Therapeutics · Open the brief
Richter Syndrome · Фаза 2 · NCT06863402
Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography, Echocardiography
Roswell Park Cancer Institute · Open the brief
Mantle Cell Lymphoma · Фаза 2 · NCT06252675
Obinutuzumab, Glofitamab, Pirtobrutinib, Tumor Imaging
University of California, San Francisco · Open the brief
T-Cell Large Granular Lymphocyte Leukemia · Фаза 2 · NCT05592015
Ruxolitinib
Jonathan Brammer · Open the brief
Waldenstrom Macroglobulinemia · Фаза 2 · NCT07231952
Pirtobrutinib, Venetoclax, Rituximab
Memorial Sloan Kettering Cancer Center · Open the brief
Autologous Stem Cell Transplant · Фаза 2 · NCT06377540
Pembrolizumab, Autologous stem cell transplant, Carmustine, Etoposide
Masonic Cancer Center, University of Minnesota · Open the brief
Large B-cell Lymphoma · Phase 1 · NCT07052305
NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma
Washington University School of Medicine · Open the brief
T-cell Acute Lymphoblastic Leukemia · Фаза 2 · NCT06514794
WU-CART-007
Allotera Therapeutics · Open the brief